Significance of stratifin in early progression of lung adenocarcinoma and its potential therapeutic relevance

2021 ◽  
Author(s):  
Aya Shiba‐Ishii
Keyword(s):  
Lung Adenocarcinoma ◽  
Therapeutic Relevance ◽  
Early Progression

Expression profile of early lung adenocarcinoma: identification ofMRP3as a molecular marker for early progression

2008 ◽  
Vol 216 (1) ◽  
pp. 75-82 ◽  
Author(s):  
S Hanada ◽  
A Maeshima ◽  
Y Matsuno ◽  
T Ohta ◽  
M Ohki ◽  
...  
Keyword(s):  
Molecular Marker ◽  
Lung Adenocarcinoma ◽  
Expression Profile ◽  
Early Progression

Abstract #619 Primary Lung Adenocarcinoma in a Sea of Metastatic Thyroid Cancer

2019 ◽  
Vol 25 ◽  
pp. 319-320
Author(s):  
Lourdes Rodriguez ◽  
Mary Baker ◽  
Daniel W Karakla ◽  
David Lieb
Keyword(s):  
Thyroid Cancer ◽  
Lung Adenocarcinoma ◽  
Primary Lung Adenocarcinoma ◽  
Metastatic Thyroid Cancer

WNT/TCF Signaling through LEF1 and HOXB9 Mediates Lung Adenocarcinoma Metastasis

2009 ◽  
Vol 138 (1) ◽  
pp. 51-62 ◽  
Author(s):  
Don X. Nguyen ◽  
Anne C. Chiang ◽  
Xiang H.-F. Zhang ◽  
Juliet Y. Kim ◽  
Mark G. Kris ◽  
...  
Keyword(s):  
Lung Adenocarcinoma

Human Chorionic Gonadotropin and CA 15-3 Producing Adenocarcinoma

1998 ◽  
Vol 37 (08) ◽  
pp. 297-298 ◽  
Author(s):  
A. Özet ◽  
A. Arpaci ◽  
S. Kömiircü ◽  
G. Üçkaya
Keyword(s):  
Lung Adenocarcinoma ◽  
Chorionic Gonadotropin ◽  
Human Chorionic Gonadotropin ◽  
Carbohydrate Antigen ◽  
Beta Subunit ◽  
Cancer Antigen ◽  
First Report ◽  
Primary Lung Adenocarcinoma ◽  
Adenocarcinoma Of Lung

Summary50 years old man suffering from primary lung adenocarcinoma presented with high levels of both beta subunit human chorionic gonadotropin (βHCG) and cancer antigen 15-3 (CA 15-3) in the absence of elevated carcinoembrionic antigen (CEA), alfa fetoprotein (AFP) and carbohydrate antigen 19-9 (CA 19-9). Although βHCG or CA 15-3 high levels were reported in adenocarcinoma of lung, this is the first report of a patient with high levels of both markers.

CD26 is overexpressed in lung adenocarcinoma and qualifies as a therapeutic target against lung cancer

2018 ◽  
Author(s):  
N Enz ◽  
F Janker ◽  
F Ramírez Fragoso ◽  
M Haberecker ◽  
A Soltermann ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Lung Adenocarcinoma ◽  
Therapeutic Target

A framework for risk stratification in EGFR+ lung adenocarcinoma treated with tyrosine kinase inhibitors

2019 ◽  
Author(s):  
P Christopoulos ◽  
M Kirchner ◽  
F Bozorgmehr ◽  
N Magios ◽  
AL Volckmar ◽  
...  
Keyword(s):  
Risk Stratification ◽  
Tyrosine Kinase ◽  
Lung Adenocarcinoma ◽  
Tyrosine Kinase Inhibitors ◽  
Kinase Inhibitors

Parallel Acquired Resistance Heterogeneity: Novel Patient Derived Synchronous Cell Pair with Distinct Mutations in an ALK-Translocated Lung Adenocarcinoma

2019 ◽  
Author(s):  
Balazs Hegedüs ◽  
Paul Stockhammer ◽  
Till Plönes ◽  
Luca Hegedüs ◽  
Agnes Bankfalvi ◽  
...  
Keyword(s):  
Lung Adenocarcinoma ◽  
Acquired Resistance ◽  
Cell Pair ◽  
Synchronous Cell

Lung adenocarcinoma in a 34-year-old female SDHB asynptomatic mutation carrier - case report

2017 ◽  
Author(s):  
Maria Joao Matos ◽  
Claudia Costa ◽  
Ana Paula Santos ◽  
Manuel Teixeira ◽  
Carlos Franco ◽  
...  
Keyword(s):  
Case Report ◽  
Lung Adenocarcinoma ◽  
Mutation Carrier
Sign in / Sign up

Export Citation Format

Share Document